About Bolder BioPath
Bolder BioPath is a company based in Boulder (United States) founded in 2003 was acquired by Inotiv in April 2021. It operates as a Professional Services. The company has 47 employees as of December 31, 2022. Bolder BioPath offers products and services including In Vivo Models, In Vitro Services, and Pathology Services. Bolder BioPath operates in a competitive market with competitors including GenOway, TransCure bioServices, InVivo Biosystems, PsychoGenics and PharmaLegacy Laboratories, among others.
- Headquarter Boulder, United States
- Employees 47 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bolder Biopath, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bolder BioPath
Bolder BioPath offers a comprehensive portfolio of products and services, including In Vivo Models, In Vitro Services, and Pathology Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
In vivo models are provided for preclinical research.
In vitro solutions are offered for decision-making support.
Pathology assessments are conducted for various disease states.
Funding Insights of Bolder BioPath
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Bolder BioPath
Bolder BioPath has secured backing from 1 investor. Prominent investors backing the company include Inotiv Co. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Clinical development and regulatory services are provided by Inotiv.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bolder BioPath
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Bolder BioPath
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bolder Biopath Comparisons
Competitors of Bolder BioPath
Bolder BioPath operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenOway, TransCure bioServices, InVivo Biosystems, PsychoGenics and PharmaLegacy Laboratories, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of transgenic rodent models and customized cell lines for preclinical development
|
|
| domain | founded_year | HQ Location |
Humanized mouse models are developed for preclinical immune drug studies.
|
|
| domain | founded_year | HQ Location |
Animal models are supplied for in-vivo analytical services.
|
|
| domain | founded_year | HQ Location |
Preclinical CRO services for CNS and orphan disorders are offered.
|
|
| domain | founded_year | HQ Location |
Preclinical CRO offering in vivo models and services for a wide range of therapeutic areas
|
|
| domain | founded_year | HQ Location |
Company offering primate models and services for preclinical drug discovery
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Bolder BioPath
When was Bolder BioPath founded?
Bolder BioPath was founded in 2003.
Where is Bolder BioPath located?
Bolder BioPath is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.
How many employees does Bolder BioPath have?
As of Dec 31, 2022, the latest employee count at Bolder BioPath is 47.
What does Bolder BioPath do?
Bolder BioPath, an Inotiv company, is focused on contract pharmacology and pathology services, specializing in in vivo models for autoimmune and inflammation conditions such as Rheumatoid Arthritis and Inflammatory Bowel Disease. Services are provided across therapeutic areas including cardiovascular, neuroscience, and oncology. Preclinical data is generated to support drug development from discovery to INDNDA stages. Solutions encompass in vitro and ex vivo analyses, safety assessments, and toxicology studies. The company caters to pharmaceutical and biotech sectors with customized research models and consultative drug discovery programs.
Who are the top competitors of Bolder BioPath?
Bolder BioPath's top competitors include GenOway, PsychoGenics and Alpha Genesis.
What products or services does Bolder BioPath offer?
Bolder BioPath offers In Vivo Models, In Vitro Services, and Pathology Services.
Who are Bolder BioPath's investors?
Bolder BioPath has 1 investor. Key investors include Inotiv Co.